Hand foot syndrome
Conditions
Interventions
Experimental group:External application of Hand-foot-yan Ning gel
Sponsors
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Patients with malignant tumors confirmed by pathology or cytology; 2. Patients with grade 1 or above hand-foot syndrome after receiving multi-target tyrosine kinase inhibitor therapy; 3. Komofsky score > 60 points; 4. No serious heart, liver, kidney and other important organ dysfunction; 5. The expected survival period is more than 3 months; 6. Aged 18 to 80 years; 7. Good compliance; 8. Voluntarily participate and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Those with preexisting nervous system diseases; 2. Diabetes complicated with nervous system diseases; 3. Patients who are receiving other non-chemotherapy drugs that may cause neurotoxicity; 4. Uncontrolled infections and metabolic diseases; 5. Pregnant women or mentally ill patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall efficiency of HFS improvement; | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement score of common symptoms of tumor;Improvement of quality of life score; | — |
Countries
China
Contacts
Public ContactChen Gang
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Outcome results
None listed